V-M Kosma

1.6k total citations
20 papers, 1.1k citations indexed

About

V-M Kosma is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, V-M Kosma has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in V-M Kosma's work include Cancer-related Molecular Pathways (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). V-M Kosma is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). V-M Kosma collaborates with scholars based in Finland, Netherlands and United States. V-M Kosma's co-authors include Markku Tammi, Raija Tammi, Reijo Sironen, Karí Syrjänen, Päivi Auvinen, Maarit Anttila, P Lipponen, S. Aaltomaa, Jari Kellokoski and Seppo Saarikoski and has published in prestigious journals such as American Journal of Clinical Nutrition, British Journal of Cancer and Experimental Cell Research.

In The Last Decade

V-M Kosma

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V-M Kosma Finland 18 553 387 275 183 165 20 1.1k
Chohei Sakakura Japan 19 542 1.0× 324 0.8× 179 0.7× 146 0.8× 326 2.0× 63 1.4k
Takayuki Mizoi Japan 17 404 0.7× 573 1.5× 85 0.3× 179 1.0× 141 0.9× 34 1.1k
Stéphanie Meier Germany 14 317 0.6× 314 0.8× 62 0.2× 72 0.4× 250 1.5× 22 910
H Sakamoto Japan 18 1.0k 1.9× 434 1.1× 205 0.7× 211 1.2× 220 1.3× 32 1.5k
G. N. Brodie Australia 12 383 0.7× 295 0.8× 89 0.3× 211 1.2× 249 1.5× 20 1.1k
Pin-Wen Lin Taiwan 17 230 0.4× 385 1.0× 101 0.4× 90 0.5× 262 1.6× 34 924
Tomoya Sakabe Japan 17 422 0.8× 264 0.7× 107 0.4× 119 0.7× 187 1.1× 26 1.2k
Hannelore Schmidt Germany 20 619 1.1× 490 1.3× 69 0.3× 176 1.0× 396 2.4× 53 1.2k
Meghna Waghray United States 15 663 1.2× 623 1.6× 69 0.3× 261 1.4× 299 1.8× 15 1.4k
Shi‐Xu Jiang Japan 19 449 0.8× 671 1.7× 72 0.3× 123 0.7× 311 1.9× 42 1.2k

Countries citing papers authored by V-M Kosma

Since Specialization
Citations

This map shows the geographic impact of V-M Kosma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V-M Kosma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V-M Kosma more than expected).

Fields of papers citing papers by V-M Kosma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V-M Kosma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V-M Kosma. The network helps show where V-M Kosma may publish in the future.

Co-authorship network of co-authors of V-M Kosma

This figure shows the co-authorship network connecting the top 25 collaborators of V-M Kosma. A scholar is included among the top collaborators of V-M Kosma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V-M Kosma. V-M Kosma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Happo, Mikko S., Raimo O. Salonen, Arja I. Hälinen, et al.. (2010). Inflammation and tissue damage in mouse lung by single and repeated dosing of urban air coarse and fine particles collected from six European cities. Inhalation Toxicology. 22(5). 402–416. 85 indexed citations
2.
Sironen, Reijo, Markku Tammi, Raija Tammi, et al.. (2010). Hyaluronan in human malignancies. Experimental Cell Research. 317(4). 383–391. 242 indexed citations
3.
Kemppainen, Tarja, Markku Heikkinen, Matti Ristikankare, V-M Kosma, & Risto Julkunen. (2009). Nutrient intakes during diets including unkilned and large amounts of oats in celiac disease. European Journal of Clinical Nutrition. 64(1). 62–67. 25 indexed citations
4.
Nyman, Heidi, Esa Jantunen, Eeva Juvonen, et al.. (2008). Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma. Bone Marrow Transplantation. 42(2). 93–98. 16 indexed citations
6.
Voutilainen, Kirsi, Maarit Anttila, Kirsi Ropponen, et al.. (2006). Prognostic significance of E-cadherin–catenin complex in epithelial ovarian cancer. Journal of Clinical Pathology. 59(5). 460–467. 59 indexed citations
7.
Leinonen, Taina, Risto Pirinen, Jan Böhm, et al.. (2006). Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer. Journal of Clinical Pathology. 60(5). 515–519. 10 indexed citations
8.
Pukkila, Matti, Jukka Virtaniemi, E. Kumpulainen, et al.. (2004). Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study. Journal of Clinical Pathology. 57(7). 735–739. 30 indexed citations
9.
Karvinen, Susanna, V-M Kosma, Markku Tammi, & Raija Tammi. (2003). Hyaluronan, CD44 and versican in epidermal keratinocyte tumours. British Journal of Dermatology. 148(1). 86–94. 48 indexed citations
10.
Hiltunen, Mikko, Mikko P. Turunen, Leea Keski‐Nisula, et al.. (2001). Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes. Gene Therapy. 8(10). 784–788. 18 indexed citations
11.
Anttila, Maarit, V-M Kosma, Jukka Puolakka, et al.. (1999). p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. British Journal of Cancer. 79(11-12). 1870–1878. 80 indexed citations
12.
Ropponen, Kirsi, Jari Kellokoski, P. Lipponen, et al.. (1999). p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. British Journal of Cancer. 81(1). 133–140. 62 indexed citations
13.
Romppanen, Jarkko, Vesa Kataja, Matti Eskelinen, et al.. (1999). Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women. British Journal of Cancer. 79(9-10). 1583–1587. 17 indexed citations
14.
Karjalainen, Jari, Matti Eskelinen, Jari Kellokoski, et al.. (1999). p21WAF1/CIP1 expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival. British Journal of Cancer. 79(5-6). 895–902. 51 indexed citations
15.
Aaltomaa, S., P Lipponen, Martti Ala‐Opas, et al.. (1999). Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. British Journal of Cancer. 80(12). 2001–2007. 70 indexed citations
17.
Nordling, Stig, et al.. (1998). Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma. British Journal of Cancer. 77(11). 1917–1925. 24 indexed citations
18.
Lipponen, P., et al.. (1996). The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer. Journal of Cancer Research and Clinical Oncology. 122(11). 687–692. 45 indexed citations
19.
Kosma, V-M, et al.. (1996). Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. British Journal of Cancer. 74(5). 766–772. 79 indexed citations
20.
Pietiläinen, Timo, P Lipponen, S. Aaltomaa, et al.. (1995). Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival.. PubMed. 15(3). 959–64. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026